RecruitingNot Applicable

ICF-Based Effects of PNF and Kinesio Taping on Hand Function in Hemiplegic Stroke

Turkey (Türkiye)54 participantsStarted 2025-06-01

Plain-language summary

This clinical trial aims to compare the effects of kinesio taping and PNF on hemiplegic hand functions. In addition, the effects of these applications on body structure, activity, and participation will be examined. The main questions it aims to answer are: Do kinesio taping and PNF applications have different effects on hemiplegic hand function? Are kinesio taping and PNF applications effective in body structure, activity, and participation? The researchers will compare the advantages of kinesio taping and PNF applications over each other. Participants: Kinesio taping and/or PNF applications will be applied 3 days a week for 8 weeks. Tests will be performed on the first and last day of the study to evaluate hand functions.

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria:Inclusion criteria for the study (Junior et al., 2019; Kim \& Kim, 2015; Saklecha et al., 2023) * Stroke diagnosed by MRI or CT, regardless of ischemic or hemorrhagic origin, * Hemiplegia caused by stroke alone, * At least 6 and at most 24 months have passed since the stroke was diagnosed * Being over 18 years of age, * Volunteering to participate in the study * Scoring 24 or more on the Standardized Mini Mental State Examination (if illiterate, scoring 18 or more is sufficient) * Cooperating with evaluation, tests and treatment * Understanding and speaking Turkish * Being at least stage 4 according to Brunnstrom staging Exclusion Criteria: * Exclusion Criteria (Junior et al., 2019; Kim \& Kim, 2015; Saklecha et al., 2023) * Individuals with bilateral hemiplegia * Individuals with unstable vital signs * Individuals with any open wound in the upper extremity * Pathological conditions affecting upper extremity sensation (undergoing surgery after fracture, etc.) * Individuals with a BMI value greater than 29.9 kg/m2 * Individuals with a Standardized Mini Mental Test score below 24 points (18 points) * Individuals with major neurological or rheumatological disorders affecting the musculoskeletal system other than stroke (Polyneuropathy, Parkinson's, Multiple Sclerosis, Rheumatoid Arthritis, etc.) * Presence of upper extremity amputation * Being at less than stage 4 according to Brunnstrom staging

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

The Fugl Meyer assessment

Timeframe: Beginning of the study and end of week 8 (when 24 sessions are completed)

Action Research Arm Test (ARAT)

Timeframe: Beginning of the study and end of week 8 (when 24 sessions are completed)

The Box-Block Test

Timeframe: Beginning of the study and end of week 8 (when 24 sessions are completed)

Nine hole Peg Test

Timeframe: Beginning of the study and end of week 8 (when 24 sessions are completed)

Trial details

NCT IDNCT07014696

SponsorIstinye University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-30

Contact for this trial

elif önder

+905453776207 elifonder2011@hotmail.com

View on ClinicalTrials.gov More Hemiplegia trials

Plain-language summary

Who can participate

Age range

18 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

What they're measuring

The Fugl Meyer assessment

Timeframe: Beginning of the study and end of week 8 (when 24 sessions are completed)

Action Research Arm Test (ARAT)

Timeframe: Beginning of the study and end of week 8 (when 24 sessions are completed)

The Box-Block Test

Timeframe: Beginning of the study and end of week 8 (when 24 sessions are completed)

Nine hole Peg Test

Timeframe: Beginning of the study and end of week 8 (when 24 sessions are completed)